ArticleAmerican journal of ophthalmology case reports2022

Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy.

Lauren A Dalvin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.